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INTRODUCTION
Primary, essential or idiopathic burning mouth 
syndrome (BMS) is characterized by a burning 
sensation in the oral mucosa and perioral areas, 
typically with bilateral, symmetric distribution and 
absent relevant clinical and laboratory findings. It 
is difficult to recognize and considered a diagnosis 
of exclusion of any detectable organic bases for 
the complaints (9,13,14). Sensation in secondary 
BMS is due to clinical abnormalities, systemic or 
psychological pathology. The diagnosis is delayed, 
often due to a lack of understanding of the nature 
of this entity, in addition to the patients taking up 
many health resources, since they frequently consult 
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various specialists (13). According to a retrospective 
study, most BMS patients are mid-life white women 
and report a sudden onset of constant oral burning 
symptoms of increasing intensity. They share oral 
symptoms for 41 months (20±73,5 months; range 
of 2-360 months). Besides 38 of 49 patients receive/
trial 71 various interventions (mean of 1,9) prior to 
receiving a definitive diagnosis for their oral burning 
symptoms that is considerably delayed (10). 
Clinical diagnosis
Dental practitioners should distinguish 
between primary and secondary BMS. The clinical 
history is helpful in diagnosing BMS. Most patients 
report an increased pain intensity from morning 
to night, a decreased pain with eating, oral dryness 
that waxes and wanes with the burning, and the 
frequent presence of taste disturbances.  Even when a 
patient reports typical BMS features, other potential 
causes should be ruled out. If burning persists after 
management of systemic or local oral conditions, 
a diagnosis of BMS can be considered. Referral to 
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a subspecialist with expertise in this area may be 
beneficial in particularly difficult cases.
However, there are no specific diagnostic 
tests for BMS. It is essential to obtain the medical, 
dental and psychological history of the patients; 
to quantify the pain on a visual analogue scale 
and to note the symptoms, duration, location and 
chronology and temporal relationship (burning/
pain), if accompanied by xerostomia and taste 
alteration, if alleviated or aggravated by foods, and 
any precipitating factors. Special attention should 
be paid to the use of medication that can produce 
xerostomia, the presence of parafunctional habits, 
and the clinical history should provide information 
on prior or current psychological and psychosocial 
stress factors (13).
An oral and extraoral examination should be 
made to discard lesions such as erythema, erosions, 
and depapillated tongue. The oral cavity should not 
dispplay any anomalies such as inflammation or 
atrophy of the mucosa at all. Possible dental problems 
should be ruled out, reviewing any prostheses and 
their occlusion, any probable oral galvanism and 
volumetric tests of saliva flow should be made (13). 
In patients with symptoms of burning in the oral 
cavity and clinically healthy oral mucosa, clinical 
examination of the oral cavity, candidal swab, 
oral galvanism measurment, salivary flow rate 
and parafunctional habit investigations should be 
performed. Detailed medical history should reveal 
any systemic factors which might result in symptoms 
of burning. If any of these known local and systemic 
causes could not be confirmed a diagnosis of ‘true’ 
BMS should be established, unfortunately, still 
without a proven cause and a limited therapeutic 
options. There is a significantly higher prevalence 
of gastritis and by 3,2 times higher incidence of 
gastrointestinal symptoms among ‘true’ BMS patients 
(12). Therefore, every patient with burning mouth 
should be referred to the gastroenterologist (2).
Laboratory diagnosis
Hematological screening (with special attention 
to serum iron, serum ferritin, blood glucose levels and 
Helicobacter pylori antibodies) should be performed 
to identify possible underlying disturbances. 
Complimentary examinations include analytical 
studies, folates, vitamin B12, zinc, serum antibodies 
in Sjögren’s syndrome and against Helicobacteer 
pylori as well as culture for the detection of Candida 
taken from the oral mucosa and palate. Epicutaneous 
tests are made on patients presenting intermittent 
symptoms (metals and other allergens used in dental 
prostheses, foods, additives) (13). Patch testing of 
75 BMS patients identified allergic reactions in 28 
of them (37,3% of the cases). The most common 
allergens were nickel sulfate hexahydrate (2,5%), 
balsam of Peru and gold sodium thiosulfate (0,5% 
each) (19).
Salivary levels of cortisol, 17β-estradiol, 
progesterone, dehydroepiandrosterone and α-amylase 
activity were estimated in unstimulated (UWS) and 
stimulated (SWS) whole saliva flow samples of 30 
female BMS patients and 20 controls. BMS showed 
significantly higher levels  of cortisol in UWS and 
of 17β-estradiol in SWS compared with controls. 
Progesterone was significantly lower in UWS of the 
patients aged over 60 years than in the younger ones 
(8). Female patients with BMS presented with a lower 
stimulated salivary flow (p<0,01) (1).
The average serum estradiol levels in women 
with BMS were low (<13 pg/mL) (15). 
Fungiform papillae density was analyzed over 
a small area of 19 mm² on the anterior tongue tip by 
means of a digital camera in 20 BMS patients and 
20 controls. This density was significantly higher 
in BMS patients as 65% of them presented with a 
density of 71-90 papillae, while 10% had even more 
than 90 papillae within this region (4).
Keratinocyte intercellular adhesion was 
evaluated by immunofluorescence of the biomarkers 
desmoglein 1, desmoglein 3 and occluding in tongue 
mucosa of BMS patients and control subjects. Besides 
keratin 10 and keratin 14, the markers of epithelial 
differentiation and keratin 16, the marker for 
activated keratinocytes after epithelial injury were 
assessed. Lingual three-dimensional architecture 
was preserved. Desmoglein 1 and desmoglein 3 
epithelial distributions in the desmosomes, keratin 
10 immunoreactivity and keratin 14 distribution 
in the epithelial compartment were similar of both 
groups. In all BMS patients, keratinocyte cytoplasm 
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was homogeneously labelled for keratin 16 and more 
intensively stained than in controls. This staining 
progressively decreased towards the most superficial 
epithelial layers. Keratin 16 mightt be involved in the 
cell mechanisms underlying BMS occurrence (18).
Oral candidiasis is not an uncommon condition 
in BMS. This can either be a primary infection 
or a secondary one to local irritation or systemic 
predisposition. Although this most often presents 
with a white, red or mixed red/white lesion, the 
visible change can be small. A direct smear is the 
ideal way to make this diagnosis rather than taking 
samples for microbiological culture as Candida 
albicans is commensal in most mouths. If candidiasis 
is suspected, a course of antifungal therapy, such as 
mycostatin, should be tried first (14). In BMS, the 
most frequent species of the genus Candida is C. 
albicans (in nine of 31 patients; 29.03%) followed 
by C. parapsilosis (in two - 6.45%); C. tropicalis, C. 
krusei and C. kefyr (in one - 3.22% each) (Cavalcanti). 
Special emphasis should be addressed at infection 
with Helicobacter pylori due to very high percentage 
(79%) of patients whose burning symptoms resolve 
after erradication therapy (2).
Functional and psychological tests
Specific techniques can be used to test for 
taste disturbance and salivary function. Autonomic 
nervous system testing, low autonomic disorder 
questionnaire, heart rate variability (HRV), deep 
breathing (exhalation/inspiration [E/I] ratio), and 
sympathetic skin response (SSR) were applied to 
33 BMS patients and 30 controls. In BMS, mean 
HRV values and E/I ratios were significantly 
lower and SSR latency in the foot was significantly 
prolonged. The autonomic questionnaire score was 
significantly higher in BMS. There was a significant 
impairment of the sympathetic and parasympathetic 
nervous systems and a preserved sympathetic/
parasympathetic balance (11).
The ability to taste bitter, acid and spicy 
substances and the thyroid function of 50 BMS 
patients and 50 controls were comparatively 
analyzed. Thirty BMS patients reported ageusia for 
bitter and two had ageusia for acid taste. Pepper 
sauce consumption produced a strong burning to the 
tongue in 28 BMS patients and in 10 controls only. 
There was biochemical evidence of hypothyroidism 
in five BMS patients, raised levels of thyroid auto-
antibodies in four ones and echographically proved 
nodularity in 34 the rest ones (7).
Due to the significant difference in anxiolytics 
intake between ‘true’ BMS and controls, psychological 
examination and counselling should be offered 
to these patients. The mean pain levels of visual 
analogue scale (VAS) are 7,5 in women and 6,11 in 
men with BMS. Other diagnostic methods include 
the number of words chosen and pain rating index 
sections of the McGill Pain Questionnaire (15).
A thorough examination was performed in 44 
patients with primary BMS. It included VAS, salivary 
flow rate measurements, laboratory tests (complete 
blood cell counts, blood glucose levels, serum iron 
and transferrin levels, serum vitamin B
12
, and folate 
levels), patch tests for contact allergy to denture 
materials, and isolation of Candida species from oral 
mucosal scrapes (6).
Differential diagnosis
Various mucocutaneous disorders are 
noteworthy. Here belong lichen planus, lichenoid 
reactions, benign mucous membrane pemphigoid, 
pemphigus and migratory glossitis. A visual clinical 
examination followed by biopsy can confirm or 
exclude this pathology. Viral diseases such as herpes 
simplex or herpes zoster can result in symptoms 
that the patient interprets as a burning sensation. 
Although these will be clinically apparent when 
the lesions erupt, there can be a prodromal burning 
sensation. The pain of post-herpetic neuralgia is 
much more severe, however, it can present as a 
burning sensation on the oral mucosa. Nutritional, 
metabolic or endocrine disorders may result in BMS, 
too. This includes diabetes mellitus, hypothyroidism, 
iron or zinc deficiency as well as vitamin B complex 
deficiency, particularly vitamin B
12
 (cobalamin), a 
common cause of macrocytic anemia (pernicious 
anemia) (13,14). Patients with true xerostomia 
present with BMS, too. This can be as a component 
of Sjögren’s syndrome, a result of radiation therapy 
to the head and neck, a side effect of medication or 
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just an age-related reduction of salivary production, 
particularly the serous component (14). 
Thus it behooves the clinician to obtain a clear 
and detailed disease and medical/dental history as 
well as perform a thorough oral clinical examination 
including any laboratory studies indicated. A 
neurological examination is useful, unless there are 
marked deficiencies, the lack of baseline data can 
present a problem. If other causes of this symptom 
are ruled out and/or the patient fails to respond to 
a normal course of treatment a diagnosis of BMS 
is reasonable (14). BMS associated to fibromyalgia 
is diagnosed in one of 41 patients with atypical or 
symptomatic facial pain (16).
In patients with Sjögren‘s syndrome or treated 
with radiotherapy for oral cancer, there is virtually 
no salivary secretion. They complain of burning 
sensation, dysguesia, difficulty in speech and there may 
be lobulation and fissuring of the tongue (1,20). The 
term of ‘scaled mouth syndrome’ was to describe the 
burning caused by angiotensin-converting enzymes 
inhibitors (3). Lithium, griseofulvin, antibiotics and 
metronidazole could cause burning sensation in the 
oral cavity (17).
In conclusion, modern interdisciplinary 
approach is needed to solve the diagnostic dilemmas 
of BMS.
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